✦ LIBER ✦

Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers

✍ Scribed by Mei Y. Yu; Joanna H.M. Tong; Paul K.S. Chan; Tin L. Lee; Michael W.Y. Chan; Anthony W.H. Chan; Kwok W. Lo; Kai F. To

Publisher: John Wiley and Sons
Year: 2003
Tongue: French
Weight: 162 KB
Volume: 105
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.11051

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Loss of heterozygosity (LOH) at chromosome 3p21 is frequent in cervical cancers. The candidate tumor suppressor gene, RASSF1A located at 3p21.3, is found to be inactivated in several major human cancers, implicating its significance in carcinogenesis. We aimed to investigate the status of RASSF1A in cervical cancers. The mutation and methylation status of RASSF1A were analysed in 4 cervical cancer cell lines, 50 primary cervical cancers including 33 squamous cell carcinoma (SCC), 17 adenocarcinoma (AC) and 11 normal controls. The primary cancer samples were also detected for LOH at 3p21 and human papillomavirus (HPV). Hypermethylation of RASSF1A was detected in 30% of SCC, 12% of AC and in 1 of the 4 cancer cell lines but was absent in all normal cases. Methylation of the cancer cell line was associated with loss of gene expression, which was restored by demethylation. About 67% (8 of 12) of hypermethylated primary cancers showed concomitant LOH at 3p21. No somatic mutation was found in all primary cancer samples or cell lines but 2 cases showed germline polymorphism at codon 133. Oncogenic HPV DNAs were found in most cancer samples. No correlation was detected between RASSF1A‐hypermethylation or LOH at 3p21 and age of patient, HPV genotype, tumor grade and stage. Hypermethylation of RASSF1A occurs in a subset of cervical cancers, among which concomitant LOH at 3p21 is common. The results supported that RASSF1A may be one of the cervical cancer‐related tumor suppressor genes located at 3p21 regions. © 2003 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Frequent loss of heterozygosity in early

Frequent loss of heterozygosity in early non-small cell lung cancers at chromosome 9p21 proximal to the CDKN2a gene

✍ Leeanne J. Mead; Matthew T. Gillespie; Jaclyn Y. Hung; Usha S. Rane; Kathleen C. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 105 KB 👁 2 views

Deletions involving the chromosome 9p21 region have been reported as frequent events in non-small cell lung cancer (NSCLC). To investigate potential tumor-suppressor gene (TSG) loci within the 9p21 region, which also harbors the candidate TSG locus CDKN2a, we studied 32 cases of primary NSCLC for lo

Frequent allelic imbalance suggests invo

Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers

✍ Shuji Nomoto; Nobuhiro Haruki; Yoshio Tatematsu; Hiroyuki Konishi; Tetsuya Mitsu 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

The short arm of chromosome 1 is among the most frequently affected regions in various types of common adult cancers as well as in neuroblastoma. In a previous study of ours, frequent allelic imbalance at the TP73 locus at 1p36 was noted in lung cancer despite the absence of TP73 mutations. This sug

Functional inactivation of the KLF6 tumo

Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma

✍ Olga Camacho-Vanegas; Goutham Narla; Miriam S. Teixeira; Analisa DiFeo; Anjan Mi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 196 KB 👁 1 views

## Abstract Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor and possesses a high incidence of 10p loss. The KLF6 (Kruppel‐like transcription factor) tumor suppressor gene on 10p15 is inactivated by loss of heterozygosity (LOH) and/or somatic mutation in a number

Frequent allelic loss at chromosome 3p d

Frequent allelic loss at chromosome 3p distinct from genetic alterations of the 8-oxoguanine DNA glycosylase 1 gene in head and neck cancer

✍ Hélène Blons; J. Pablo Radicella; Ollivier Laccourreye; Daniel Brasnu; Philippe 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

Cigarette smoking is the major known risk factor for head and neck cancer. Tobacco promotes oxidative stress and enhances tissue levels of 8-hydroxyguanine (8-OH-G) in smokers. The presence of 8-OH-G does not impede replication but leads to an accumulation of G 3 T transversions. Recently, the gene